AI Article Synopsis
- Moderate-to-severe psoriasis often requires systemic therapy but is frequently undertreated; this study explores treatment patterns in the U.S. from 1993 to 2010.
- Data analysis reveals that while overall systemic treatment usage hasn't increased, the use of phototherapy has significantly declined, and biologics became the most common treatment after their introduction in 2002.
- Despite the rise in biologics, there is still evidence of under-treatment for moderate-to-severe psoriasis, as the frequency of systemic treatments remained relatively stagnant during the 18-year study period.
Article Abstract
Background: Moderate-to-severe psoriasis generally requires systemic therapy, and is often undertreated.
Objective: To determine and analyze what courses of treatment and in what frequency are being utilized to combat psoriasis in the United States.
Methods: Analysis of data from the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS) of the National Center for Health Statistics. Data were analyzed to examine the prevalence of different therapy techniques to combat psoriasis from 1993 through 2010. The trends for phototherapy, methotrexate (MTX), retinoids, cyclosporine A (CSA), systemic steroids, and biologics were all analyzed over the entire 18-year period and independently before and after the introduction of biologics in 2002.
Results: From 1993 to 2010, the trend for total systemic treatments has not significantly increased (P=0.5). Frequency of phototherapy treatments significantly decreased from 1993 to 2010 (P<0.001). Since the introduction of biologics in 2002, their frequency has significantly increased, becoming the most frequently used treatment from 2008-2010 (P<0.0001).
Limitations: Severity of psoriasis was not recorded in the NAMCS and NHAMCS.
Conclusions: The frequency of systemic treatments to treat psoriasis has not significantly increased from 1993 to 2010. Despite the introduction of biologics, it appears that little progress has been made in reducing under-treatment of moderate-to-severe psoriasis.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Proton Pump Inhibitor Use and Incident Cardiovascular Disease in Older Postmenopausal Women.
J Am Geriatr Soc
December 2024
Department of Epidemiology and Environmental Health, University at Buffalo - SUNY, Buffalo, New York, USA.
Background: Epidemiological studies have been inconsistent regarding an association between proton pump inhibitor (PPI) use and risk of primary cardiovascular disease (CVD) events.
Methods: We studied 85,189 postmenopausal women (mean age 63 years at baseline) without known CVD at enrollment into the Women's Health Initiative Observational Study (1993-1998). PPI use was determined from medication inventories at baseline and Year-3.
Zambia's battle against cholera outbreaks and the path to public health resilience: a narrative review.
J Water Health
December 2024
Institute for Water Research (IWR), Rhodes University, Old Geology Building (off Artillery Road), P.O. Box 94, Grahamstown 6140, South Africa.
In Zambia, cholera has been a persistent public health concern for decades, mainly attributed to inadequate sanitation and restricted access to clean water in some parts of the country. The literature was collected from PubMed, Google Scholar, and public health organization websites, focusing on cholera outbreaks in Zambia since 2000. Key search terms included 'cholera prevention' and 'Zambia outbreaks.
View Article and Find Full Text PDFGlobal incidence and prevalence in uveal melanoma.
Adv Ophthalmol Pract Res
October 2024
Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Purpose: The most common intraocular cancer in adults is uveal melanoma (UM). This study aimed to investigate and report the incidence and prognosis of UM in different regions of the world.
Methods: We retrieved relevant data on UM from the PubMed database and analyzed its global incidence and prognosis.
A prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the recombinant zoster vaccine in Chinese adults ≥50 years of age.
Hum Vaccin Immunother
December 2024
GSK, Rockville, USA.
This post-marketing surveillance study evaluated the safety of the adjuvanted recombinant zoster vaccine (RZV) in Chinese adults, given the limited country-specific safety data accumulated since the 2019 licensure of RZV in China for adults ≥ 50 years of age (YOA). This descriptive, prospective cohort study enrolled adults ≥ 50 YOA who voluntarily received RZV per routine clinical practice in six centers in China. The primary outcomes were occurrence, intensity, and causal relationship to vaccination of medically attended adverse events (MAEs) within 30 days post-any dose.
View Article and Find Full Text PDFFirst Report of Maize Ear Rot Caused by in Serbia.
Plant Dis
December 2024
Maize Research Institute, Phytopathology, Belgrade, Serbia;
Fusarium graminearum species complex (FGSC) includes at least fifteen species which are some of the most significant fungi that infect maize in temperate areas (Sarver et al. 2011). Agroecological conditions in Serbia are suitable for the development of infection by members of FGSC and therefore during the period of 1993-2010, maize samples collected from northern Serbia (46°5'55" N, 19°39'47" E) showed typical symptoms of gibberella ear rot.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!